Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
LEUKOTRIENE B4 DERIVATIVES, IN PARTICULAR OXIMO-LTB4 ANTAGONISTS
Document Type and Number:
WIPO Patent Application WO1998052915
Kind Code:
A3
Abstract:
PCT No. PCT/EP98/03139 Sec. 371 Date Mar. 27, 2000 Sec. 102(e) Date Mar. 27, 2000 PCT Filed May 22, 1998 PCT Pub. No. WO98/52915 PCT Pub. Date Nov. 26, 1998Leukotriene-B4 derivatives of general formula (I), in which R1 represents H, CF3, CH2OH, and R2 represents H or an organic acid radical; R3 symbolizes H, C1-C14 alkyl, C3-C10 cycloalkyl, or a 5- to 6-membered aromatic heterocyclic ring with at least 1 heteroatom; R4 means hydrogen, C1-C10 alkyl, C3-C10 cycloalkyl; A symbolizes a trans, trans-CH=CH-CH=CH, a -CH2CH2-CH=CH- or a tetramethylene group; B symbolizes a C1-C10- straight-chain or branched-chain alkylene group or group (a) or (b); D can mean a direct bond, oxygen, sulfur, -C 3BOND C-, -CH=CR7, or together with B can also mean a direct bond; R5 and R6 are the same or different and represent H or C1-C4 alkyl, or R6 represents H and R5 represents C1-C15 alkanoyl or R8 represents SO2; R7 means H, C1-C5 alkyl, chlorine, bromine; R8 has the same meaning as R3, m means 1-3, o means 0-5, p means 0-5, X is a direct bond, oxygen, sulfur, an aromatic compound or heteroaromatic compound, Y is a C1-C8 alkyl, C3-C10 cycloalkyl, n is 2-5, and, if R4 means hydrogen, their salts with physiologically compatible bases and their cyclodextrin clathrates. The leukotriene derivatives are used as dermatological products.

Inventors:
BUCHMANN BERND (DE)
FROEHLICH WOLFGANG (DE)
GIESEN CLAUDIA (DE)
HENNEKES HARTWIG (DE)
JAROCH STEFAN (DE)
SKUBALLA WERNER (DE)
Application Number:
PCT/EP1998/003139
Publication Date:
February 25, 1999
Filing Date:
May 22, 1998
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SCHERING AG (DE)
BUCHMANN BERND (DE)
FROEHLICH WOLFGANG (DE)
GIESEN CLAUDIA (DE)
HENNEKES HARTWIG (DE)
JAROCH STEFAN (DE)
SKUBALLA WERNER (DE)
International Classes:
A61K31/19; A61K31/23; A61K31/557; A61K31/5575; A61P17/00; A61P29/00; A61P37/08; A61P43/00; C07C403/08; C07C405/00; C07D251/44; C07D251/50; C07D251/54; C07D251/60; C07D257/04; C07D257/06; C07D277/24; C07D277/28; C07D277/56; (IPC1-7): C07C405/00
Domestic Patent References:
WO1995020563A11995-08-03
Foreign References:
EP0581187A11994-02-02
Other References:
VLATTAS, ISIDOROS ET AL: "O-(1-Alkyl- or arylthioalkyl)hydroxylamines. New class of oxime reagents, their preparation, and synthetic utility", J. ORG. CHEM. (1973), 38(21), 3749-52 CODEN: JOCEAH, 1973, XP002084528
HAMANAKA, NOBUYUKI ET AL: "Molecular design of novel PGI2 agonists without PG skeleton. II", BIOORG. MED. CHEM. LETT. (1995), 5(10), 1071-6 CODEN: BMCLE8;ISSN: 0960-894X, 1995, XP002084529
Download PDF: